Top Biopolitical Times blog posts of 2010
Posted by Jillian Theil December 22, 2010
Biopolitical Times
![Default Image](/sites/default/files/styles/teaser/public/default_images/default.jpg?itok=6mH2DjpO)
Once again, the bloggers at Biopolitical Times and other CGS staff were polled for our favorite posts of the closing year. In alphabetical order:
- Egg Raffles and Shadow Markets: The Fertility Industry Goes Global - and Skirts Laws
The baby business has become a transnational enterprise. As in other aspects of global commerce, the lowest level of labor and consumer protection tends to prevail. - Gopher Kids or Guinea Pigs?
University of Minnesota researchers attempting to investigate the genetic features of “normal and healthy” kids plan to solicit DNA samples from child-parent volunteer pairs at this month’s state fair. - No Laughing Matter: The Risks that Human Research Subjects Face
Joking about putting human research subjects into harm’s way isn’t funny. - One of the Leading Scientists in the World?
Robert Lanza, the Chief Scientific Officer of Advanced Cell Technology, projects great self-confidence, but is it justified? - Politics Belong in Science
Reflecting on Venter's recent announcement and Obama's call to study Synthetic Biology, Time's Nancy Gibbs clarifies that political engagement with science is essential. - Race, Genetics, and Law School Emails
The blogosphere was recently set ablaze by a leaked email from a third year Harvard Law student who, after a dinner with friends, wrote to clarify his/her position on race, genetics, and intelligence. - The Corrupting Influence of the Business of Biotech
Many scientists seem oblivious of the potential that industry funding offers for conflicts of interest. - The "Medical" Justification for Re-creating Neanderthals
"Should We Clone Neanderthals?" asks an article in Archaeology magazine. - Transhumanist Fantasylands – Way Out There on the Political Horizon
“And you thought the guys who had their heads sawed off and frozen in a cryogenic chamber were hardcore.” - Whither Personal Genomics?
Three companies offer contrasting examples of where the fledgling industry goes from here.